Baltimore News Journal – Lifestyle

Author: BEIJING CHENGUANG PHARMACEUTICAL TECHNOLOGY CO., LTD.

Dayspring Pharma Announces Phase II Trial of CG2001 Foam Met Primary Endpoint in Chinese Adult Men with AGA

April 21, 2026